James E Barrett Selected Research

1,2,3,4,8,9,10,10a- octahydro- 7bH- cyclopenta(b)(1,4)diazepino(6,7,1hj)indole

6/2007	Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents.
1/2007	WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James E Barrett Research Topics

Disease

12	Pain (Aches) 01/2022 - 11/2011
6	Neoplasms (Cancer) 01/2022 - 12/2014
4	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2014
4	Chronic Pain 01/2019 - 11/2011
4	Hypersensitivity (Allergy) 01/2018 - 12/2012
4	Neuralgia (Stump Neuralgia) 01/2017 - 12/2012
3	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2020 - 09/2009
3	Complex Regional Pain Syndromes 01/2019 - 11/2011
3	Mental Disorders (Mental Disorder) 11/2011 - 09/2009
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2022
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 10/2017
2	Inflammation (Inflammations) 01/2019 - 01/2018
2	Acute Pain 01/2018 - 10/2013
2	Hyperalgesia 01/2018 - 10/2013
2	Bipolar Disorder (Manic Depressive Psychosis) 11/2011 - 09/2009
2	Depressive Disorder (Melancholia) 04/2011 - 02/2004
2	Major Depressive Disorder (Major Depressive Disorders) 04/2011 - 09/2009
2	Schizophrenia (Dementia Praecox) 09/2009 - 01/2007
1	Triple Negative Breast Neoplasms 01/2022
1	Hemorrhage 01/2022
1	Endometrial Neoplasms (Endometrial Cancer) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 11/2021
1	Infarction (Infarctions) 01/2018
1	Stroke (Strokes) 01/2018
1	Atherosclerosis 01/2018
1	Cerebral Infarction 01/2018
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2018
1	Thrombophilia 01/2018
1	Lung Neoplasms (Lung Cancer) 07/2017
1	Peripheral Nervous System Diseases (PNS Diseases) 03/2015
1	Neoplasm Metastasis (Metastasis) 12/2014
1	Edema (Dropsy) 10/2013
1	Neurogenic Inflammation 11/2011

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2009
5	MicroRNAs (MicroRNA)IBA 01/2022 - 11/2011
5	Analgesics (Analgesic Drugs)IBA 11/2021 - 12/2012
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 02/2004
3	Freund's AdjuvantIBA 01/2016 - 12/2012
3	Messenger RNA (mRNA)IBA 11/2011 - 09/2009
3	Antidepressive Agents (Antidepressants)IBA 06/2007 - 01/2003
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2022
2	Progesterone FDA LinkGeneric 01/2022 - 01/2022
2	Formaldehyde (Formol)FDA Link 11/2021 - 01/2018
2	Opioid Analgesics (Opioids)IBA 11/2021 - 01/2016
2	quisinostatIBA 01/2016 - 03/2015
2	Histone Deacetylase InhibitorsIBA 01/2016 - 03/2015
2	CytokinesIBA 10/2013 - 11/2011
2	1,2,3,4,8,9,10,10a- octahydro- 7bH- cyclopenta(b)(1,4)diazepino(6,7,1hj)indoleIBA 06/2007 - 01/2007
1	Progestins (Progestagens)IBA 01/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2022
1	Levonorgestrel (Plan B)FDA LinkGeneric 01/2022
1	Estrogens (Estrogen)FDA Link 01/2022
1	VaccinesIBA 01/2022
1	VitaminsIBA 01/2022
1	A-Form DNA (A-DNA)IBA 01/2022
1	Mifepristone (RU 486)FDA Link 01/2022
1	Hormones (Hormone)IBA 01/2022
1	ulipristal acetate FDA Link 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Chemokine ReceptorsIBA 11/2021
1	Morphine (MS Contin)FDA LinkGeneric 11/2021
1	ImmunophilinsIBA 01/2020
1	GlucocorticoidsIBA 01/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	Cetuximab (Erbitux)FDA Link 01/2020
1	Lipoproteins (Lipoprotein)IBA 01/2018
1	Complement C1s (C1 Esterase)IBA 01/2018
1	CarrageenanIBA 01/2018
1	Blood Proteins (Serum Proteins)IBA 01/2018
1	GelsolinIBA 01/2018
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 01/2018
1	Potassium Channels (Potassium Channel)IBA 01/2018
1	Calcium Release Activated Calcium ChannelsIBA 01/2018
1	hydrogen sulfite (bisulfite)IBA 07/2017
1	Purinergic P2X7 ReceptorsIBA 01/2017
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2016
1	Circulating MicroRNAIBA 01/2016
1	Ketamine FDA LinkGeneric 09/2015
1	Gabapentin (Neurontin)FDA LinkGeneric 03/2015
1	Histone Deacetylases (Histone Deacetylase)IBA 03/2015
1	Protein Kinases (Protein Kinase)IBA 12/2014
1	ezrinIBA 12/2014
1	Actin Depolymerizing Factors (Cofilins)IBA 12/2014
1	AntigensIBA 10/2013
1	Dinoprostone (PGE2)FDA Link 10/2013
1	4- methyl- 4'- (3,5- bis(trifluoromethyl)- 1H- pyrazol- 1- yl)- 1,2,3- thiadiazole- 5- carboxanilideIBA 10/2013
1	Menthol FDA Link 12/2012
1	Anticonvulsants (Antiepileptic Drugs)IBA 11/2011
1	Narcotics (Narcotic Analgesics)IBA 11/2011

Therapy/Procedure

5	Therapeutics 10/2017 - 02/2004
3	Drug Therapy (Chemotherapy) 01/2020 - 03/2015
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2022
1	Aftercare (After-Treatment) 01/2022
1	Analgesia 11/2021
1	Plasma Exchange 01/2019
1	Self Administration (Administration, Self) 01/2016
1	Ligation 01/2016
1	Oral Administration 10/2013